Related Experiment Video
Updated: May 16, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Foetal haemoglobin and the dynamics of paediatric malaria
Erica M W Billig1, Philip G McQueen, F Ellis McKenzie
1National Institutes of Health, Fogarty International Center, Building 16, Room 303, Bethesda, MD 20892, USA. erica.billig@nih.gov
Insights
Foetal haemoglobin (HbF) and red blood cell (RBC) count likely protect infants from malaria. HbF inhibits parasite growth, reducing malaria severity in young children.
Area of Science:
- Paediatric infectious diseases
- Mathematical modelling of biological systems
- Haematology
Background:
- Infants under six months exhibit lower malaria infection rates despite high prevalence in children under five.
- Potential protective factors include maternal antibodies, breastfeeding, and foetal haemoglobin (HbF).
Purpose of the Study:
- To investigate mechanisms protecting infants from malaria using mathematical modelling.
- To explore the impact of foetal haemoglobin (HbF) and red blood cell (RBC) changes on parasite dynamics.
Main Methods:
- Developed ordinary differential equations to model parasite growth within RBCs.
- Incorporated HbF's effect on parasite multiplication, blood volume, haematocrit, and parasite affinity for specific RBC types.
Main Results:
- Model simulations showed protection in infants under specific conditions, including reduced parasite multiplication in HbF-containing RBCs.
- Inhibition of schizont division in foetal RBCs emerged as a key protective mechanism.
- Parasite preference for HbF-RBCs enhanced protection, while reticulocyte preference had minimal impact.
Conclusions:
- Foetal haemoglobin (HbF) and RBC count are crucial factors in paediatric malaria protection.
- Findings provide a framework for future empirical research on infant malaria.
- Mathematical modelling offers insights into complex host-parasite dynamics.
Background:
Although 80% of malaria occurs in children under five years of age, infants under six months of age are known to have low rates of infection and disease. It is not clear why this youngest age group is protected; possible factors include maternal antibodies, unique nutrition (breast milk), and the presence of foetal haemoglobin (HbF). This work aims to gain insight into possible mechanisms of protection, and suggest pathways for focused empirical work, by modelling a range of possible effects of foetal haemoglobin and other red blood cell (RBC) developmental changes on parasite dynamics in infants.
Methods:
A set of ordinary differential equations was created to investigate the leading hypotheses about the possible protective mechanisms of HbF-containing red blood cells, in particular whether HbF suppresses parasite population growth because parasite multiplication in individual RBCs is lower, slower or absent. The model also incorporated the intrinsic changes in blood volume and haematocrit that occur with age, and the possibility of parasite affinities for HbF-containing RBCs or reticulocytes.
Results:
The model identified several sets of conditions in which the infant remained protected, or displayed a much slower growth of parasitaemia in the first few months of life, without any intervening immune response. The most protective of the hypothesized mechanisms would be the inhibition of schizont division in foetal RBCs so that fewer merozoites are produced. The model showed that a parasite preference for HbF-containing RBCs increases protective effects for the host, while a preference for reticulocytes has little effect.
Conclusions:
The results from this simple model of haematological changes in infants and their effects on Plasmodium falciparum infection dynamics emphasize the likely importance of HbF and RBC number as an explanatory factor in paediatric malaria, and suggest a framework for organizing related empirical research.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Rh Blood Group

